Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)

PURPOSE: Although S-1 based chemotherapy for patients with advanced gastric cancer has generally been accepted in Japan, discontinuations of treatment have been reported due to grade 3 or more adverse events. The present randomized phase II study was conducted to test whether alternate-day administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hiroaki, Kanda, Mitsuro, Morita, Satoshi, Taguri, Masataka, Nishikawa, Kazuhiro, Shimada, Mitsuo, Muguruma, Kazuya, Koeda, Keisuke, Takahashi, Masazumi, Nakamori, Mikihito, Konno, Hiroyuki, Tsuji, Akihito, Hosoya, Yoshinori, Shirasaka, Tetsuhiko, Yamamitsu, Susumu, Sowa, Michio, Kitajima, Masaki, Okajima, Masazumi, Kobayashi, Michiya, Sakamoto, Junichi, Saji, Shigetoyo, Hirakawa, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677054/
https://www.ncbi.nlm.nih.gov/pubmed/28667408
http://dx.doi.org/10.1007/s10147-017-1157-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677054/
https://www.ncbi.nlm.nih.gov/pubmed/28667408
http://dx.doi.org/10.1007/s10147-017-1157-3

Ejemplares similares